Botulism future or investigational therapies: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Botulism}} | {{Botulism}} | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
{{CMG}} | {{CMG}} | ||
Revision as of 18:50, 18 December 2012
|
Botulism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Botulism future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Botulism future or investigational therapies |
|
Risk calculators and risk factors for Botulism future or investigational therapies |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.
Overview
Classically, the treatment for botulism has been to deliver an antitoxin to the patient once exposed. Also, putting the patient on a mechanical ventilator has been a successful treatment method because patients with botulism have extreme trouble breathing on their own. Even though these treatments have been successful, there have been tests on a new drug that will block Potassium channels in order to restore neuromuscular function after botulinum intoxication.